Silexion Therapeutics Corp. (SLXN)
NASDAQ · Healthcare
Silexion Therapeutics Corp. Operating Income 2023–2025
Silexion Therapeutics Corp. annual/quarterly operating income history and growth rate from 2023 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Silexion Therapeutics Corp. operating income for the quarter ending March 31, 2026 was -2.7 M, a 66.61% increase year-over-year.
- Silexion Therapeutics Corp. operating income for the twelve months ending March 31, 2026 was -10.0 M.
- Silexion Therapeutics Corp. annual operating income for 2025 was -11.6 M, a 7.47% decrease from 2024.
- Silexion Therapeutics Corp. annual operating income for 2024 was -12.6 M, a 168.55% increase from 2023.
- Silexion Therapeutics Corp. annual operating income for 2023 was -4.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Silexion Therapeutics Corp. Operating Income — FAQ
Silexion Therapeutics Corp. (SLXN) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Silexion Therapeutics Corp.'s operating income?
Silexion Therapeutics Corp. (SLXN) reported operating income of -$12M for fiscal 2025.
Where can I see SLXN's operating income history?
The chart and table above show Silexion Therapeutics Corp.'s operating income by year and by quarter, including the growth rate.